Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
ipo
2
×
life sciences
national blog main
2
×
new york blog main
new york top stories
acetylon pharmaceuticals
agios pharmaceuticals
ambys medicines
cancer
cancer drugs
cell therapy
clinical trials
constellation pharmaceuticals
david e. shaw
deals
drug discovery
enasidenib
fda
gene therapy
genentech
holger willenbring
investing
ivosidenib
jeffrey tong
juan carlos izpisua belmonte
keith dionne
liver disease
markus grompe
martin burke
materials science
morphic
national top stories
new york
nimbus therapeutics
oregon stem cell center
proteon therapeutics
salk institute for biological studies
What
medicines
today
2
×
aiming
ambys
big
biotech
company’s
control
course
deadly
deal
debuted
development
discover
diseases
experimental
formed
future
growing
handiwork
helped
internal
ipo
landscape
launch
liver
make
new
pipeline
scan
schrödinger
schrödinger’s
sets
software
spot
startup
support
takeda
treatments
unusual
Language
unset
Current search:
ipo
×
today
×
" national blog main "
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
